Cargando…
Cilomilast Ameliorates Renal Tubulointerstitial Fibrosis by Inhibiting the TGF-β1-Smad2/3 Signaling Pathway
Background: Renal tubulointerstitial fibrosis is the key pathological feature in chronic kidney diseases (CKDs) with no satisfactory therapies in clinic. Cilomilast is a second-generation, selective phosphodiesterase-4 inhibitor, but its role in renal tubulointerstitial fibrosis in CKD remains uncle...
Autores principales: | Xu, Man, Li, Shumin, Wang, Jiajia, Huang, Songming, Zhang, Aihua, Zhang, Yue, Gu, Wei, Yu, Xiaowen, Jia, Zhanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859332/ https://www.ncbi.nlm.nih.gov/pubmed/33553218 http://dx.doi.org/10.3389/fmed.2020.626140 |
Ejemplares similares
-
TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
por: Yu, Xiao-Yong, et al.
Publicado: (2022) -
Plk1 promotes renal tubulointerstitial fibrosis by targeting autophagy/lysosome axis
por: Du, Yang, et al.
Publicado: (2023) -
Irisin Ameliorates Renal Tubulointerstitial Fibrosis by Regulating the Smad4/β-Catenin Pathway in Diabetic Mice
por: Yang, Zhaohua, et al.
Publicado: (2023) -
A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling
por: He, Xuemin, et al.
Publicado: (2020) -
TGF-β/Smad signaling in renal fibrosis
por: Meng, Xiao-Ming, et al.
Publicado: (2015)